Skip to evidence report

NEU.INH_VIP.develop_niche: Studies — page 8

How association tiers are defined — cell–trait and gene–trait

SCREATE tier definitions supplied by the atlas curator. This methods note explains the prepared classifications; it does not recompute or change any report scores or tiers.

Cell–trait tiers

Cell–trait links
Identify cell types whose regulatory activity is associated with a trait’s genetic signal.
Required for Specific or Relevant
The ICE-CREAM score derived from the mean metacell Z score must be ≥ 5.39, with BOTH nominal and adjusted ICE-CREAM P values ≤ 0.05.
Specific (Tier 1)
Also meets all cell-set enrichment analysis (CSEA) criteria in at least one tested comparison: nominal P ≤ 0.05 AND adjusted P ≤ 0.05 AND normalized enrichment score (NES) ≥ 1, all in that comparison. This indicates that trait-associated activity is concentrated in this cell type relative to the tested background.
Relevant (Tier 2)
Meets the ICE-CREAM requirements but not the additional CSEA criteria. The cell type may share trait-associated activity with other cell types.
Interpretation and report values
CSEA is cell-set enrichment analysis, analogous to gene-set enrichment analysis but using sets of cells along a ranked list of ICE-CREAM scores. The eligibility score derived from the mean metacell Z score is not the displayed mean IC score. Do not infer a tier from the displayed mean, its descriptive Significance column, or a single CSEA summary value. Reports preserve prepared tiers; Other means an available association outside Specific/Relevant, and unavailable is not zero or proof of biological irrelevance.
Meta traits and individual traits
Use the prepared tier for the exact meta trait or individual trait. A meta trait’s Best child CSEA FDR is the lowest available child FDR, not a combined or meta-trait significance test. Its displayed mean child NES is descriptive, not a new CSEA test. These summaries must not be used to reconstruct or override the meta-trait tier.

Gene–trait priorities (variant–tCRE–gene evidence)

Variant–tCRE–gene links
Candidate variants connect to genes through overlapping promoters or distal transcribed cis-regulatory elements (tCREs) linked to gene promoters by the Activity-by-Contact (ABC) model.
Required genetic support
The variant belongs to a purity-passing SuSiE credible set OR qualifies for Borzoi rescue. Borzoi rescue requires BOTH a variant-causality score ≥ 0.3 AND linkage disequilibrium with the lead variant of r² ≥ 0.2.
Required cellular support
The overlapping promoter has positive tCRE activity OR the distal element has a passing cell-specific ABC link to the gene, in a Specific or Relevant cell subtype (L1S) or fine-grained state (L2). BOTH genetic and cellular support are required for High or Medium priority.
High priority
Among records meeting both minimum requirements, High requires a genetic score ≥ 0.5 AND a Layer 1 correlation > 0.3 between tCRE activity and the trait’s cellular profile across cell subtypes.
Medium priority
Meets both minimum requirements but not one or both additional High thresholds. The genetic score is the higher of the SuSiE posterior inclusion probability (PIP) and the Borzoi variant-causality score.
Same-record evidence and aggregation
Each priority requires genetic and cellular evidence supporting the SAME variant–tCRE–gene record. Do not combine thresholds or evidence from different records to create a qualifying link. A gene receives the highest priority observed among its supporting records. A tCRE summary uses supporting records for that exact tCRE, not every trait of its linked genes. Separately displayed aggregate scores do not relax the same-record rule.
Limits of interpretation
A priority is candidate-association evidence, not proof of a causal variant, causal gene, causal cell type or treatment efficacy. Missing evidence is unavailable, not zero. MAGMA −log10(P), displayed credibility scores, cellular-context scores and G/C tier codes must not be substituted for these eligibility tests; use the provided records and their documented fields.

State · 122 full-atlas cells · all tissues.

Marker genes and cell annotation · Open this population in Cell Browser →

ICE-CREAM (IC) is −log10(P) from a permutation test. An IC score of 3 corresponds to an unadjusted P value of 0.001; 5.5 is the multiple-testing-corrected significance threshold across all metacells. The Significance categories are Significant for IC > 5.5, Nominal for 3 ≤ IC ≤ 5.5, and Nonsignificant for IC < 3. These reports display mean IC scores across full-atlas populations, not the UMAP sample. The categories apply to the displayed scores: a cell-group mean or an average across individual traits is descriptive and is not itself a newly tested P value or a new multiple-testing correction. All scores are retained. Enrichment is not proof of causality or treatment efficacy.

Rows 7,001–8,000 of 12,313; ranked by score descending. Equal values use name/identifier order.

Studies ranked for NEU.INH_VIP.develop_niche
#Trait / studyIndividual trait IDMean IC score
7001Thyroiditis, unspecifiedFING000013590.01
7002GRAP2/SRC ratioGCST903149890.01
7003Glucose levels (UKB data field 23470)GCST902695670.01
7004Blood urea nitrogen levelsGCST900187280.01
7005T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 118)GCST903209370.01
7006Early lumbar disc prolapse, operatedFING000004840.01
7007Placental weight (maternal genotype, adjusted for sex)GCST902751980.01
7008MME/NT5E ratioGCST903154600.01
7009Estimated glomerular filtration rate based on creatinine and cystatin C in bottom 99% of individuals by creatinine levelsGCST905667370.01
7010ANG/RARRES2 ratioGCST903132710.01
7011EHD3 levelsGCST904690890.01
7012Vitamin D | Blood biochemistryUKBB000009020.01
7013NUBP1 levelsGCST904701000.01
7014Volume of left anterior amygdaloid areaGCST904749370.01
7015Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T251ECGA0002510.01
7016RAB31 levelsGCST900875520.01
7017Mean sphered cell volume (UKB data field 30270)GCST904680890.01
7018Familial combined hyperlipidemia defined by Brunzell criteriaGCST901040030.01
7019Triglyceride levels in very small VLDLGCST900930380.01
7020T1 FreeSurfer a2009s rh S calcarine areaGCST903849330.01
7021Tibia length to body height ratioGCST902702580.01
7022Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T164ECGA0001640.01
7023ECE1 levelsGCST904690610.01
7024Total concentration of lipoprotein particles (UKB data field 23427)GCST902695240.01
7025AKT1S1/FHIT ratioGCST903132280.01
7026ANP32B levelsGCST902401760.01
7027Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T151ECGA0001510.01
7028Prostate cancerGCST902747140.01
7029T1 FreeSurfer aseg Right-PallidumGCST903841640.01
7030Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T250ECGA0002500.01
7031Coronary artery bypass graftingFING000003580.01
7032IDP dMRI TBSS OD Superior corona radiata LGCST900044270.01
7033SAP18 levelsGCST902414320.01
7034NOS1 levelsGCST904700620.01
7035COMP/THBS4 ratioGCST903141930.01
7036Triglycerides in VLDL (UKB data field 23408)GCST902695050.01
7037T1 FreeSurfer a2009s lh S temporal sup areaGCST903847400.01
7038Non-cancer illness code, self-reported - eczema/dermatitis | Medical conditionsUKBB000005090.01
7039Linoleic acid levelsGCST904983090.01
7040Testosterone levelsGCST904834860.01
7041ENO2/ITGB1BP2 ratioGCST903146610.01
7042DSG4 levelsGCST904690440.01
7043T1 FreeSurfer DKT rh lingual areaGCST903842970.01
7044CD84/TREML2 ratioGCST903139190.01
7045aparc-a2009s rh volume S-front-infGCST900030500.01
7046HippSubfield lh volume CA3-bodyGCST900026800.01
7047AGRP/NPY ratioGCST903132030.01
7048LAT/VASH1 ratioGCST903152890.01
7049Right-hemisphere visual network to right-hemisphere somatomotor network white-matter structural connectivityGCST903027750.01
7050Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T174ECGA0001740.01
7051wg rh intensity-contrast parsorbitalisGCST900038450.01
7052Unstable angina pectorisGCST900187120.01
7053CCN2/DKK1 ratioGCST903137100.01
7054UFC1 levelsGCST902432450.01
7055Ventricular arrhythmiaGCST900187200.01
7056LCN2/RETN ratioGCST903153080.01
7057LYPD8 levelsGCST904698290.01
7058Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T130ECGA0001300.01
7059Intra-ocular pressure, Goldmann-correlated (left) | Intraocular pressureUKBB000003760.01
7060Total lipids in small HDLGCST904994560.01
7061HippSubfield rh volume hippocampal-fissureGCST900026940.01
7062BCAM/NOTCH1 ratioGCST903134740.01
7063Sphingomyelin_41:0_[M+H]1+ levelsGCST900603860.01
7064Other non-epithelial cancer of skin (PheCode 172.2)GCST904755800.01
7065Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T157ECGU0001570.01
7066Intra-ocular pressure, corneal-compensated (left) | Intraocular pressureUKBB000003740.01
7067SPRY2/YTHDF3 ratioGCST903158810.01
7068FTCD levelsGCST904692740.01
7069Diastolic blood pressure (MTAG)GCST904490570.01
7070Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T423ECGU0004230.01
7071Polyunsaturated fatty acids to monounsaturated fatty acids ratioGCST904992870.01
7072Non-cancer illness code, self-reported - heart attack/myocardial infarction | Medical conditionsUKBB000005140.01
7073FAM171B levelsGCST900903390.01
7074SPINK5/SPINT1 ratioGCST903158770.01
7075Kidney transplant statusFING000007100.01
7076Hair/balding pattern: Pattern 4 (UKB data field 2395_4)GCST900436190.01
7077Phenylalanine levelsGCST904992280.01
7078Stenosis and insufficiency of lacrimal passagesFING000013340.01
7079NCS1 levelsGCST904700110.01
7080DTI TBSS L2 Anterior corona radiata LGCST903844990.01
7081Vitamin B12 deficiency anaemiaFING000014410.01
7082Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T273ECGA0002730.01
7083TAX1BP1 levelsGCST904708080.01
7084DCTN1/SCAMP3 ratioGCST903144330.01
7085Urinary tryptophan to urinary creatinine ratioGCST904517480.01
7086HCLS1/TMSB10 ratioGCST903150430.01
7087Cholesterol esters in very small VLDLGCST905007400.01
7088Free cholesterol in IDLGCST904975610.01
7089BLMH levelsGCST904684470.01
7090HerniaFING000006160.01
7091CLC levelsGCST904687620.01
7092Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T156ECGU0001560.01
7093DEFB4A or DEFB4B levelsGCST904689840.01
7094Other disorders of glucose regulation and pancreatic internal secretionFING000010280.01
7095IDP dMRI TBSS L2 Cerebral peduncle RGCST900041370.01
7096Coeliac diseaseGCST904681200.01
7097DTI TBSS L2 Medial lemniscus LGCST903844850.01
7098Left ventricle sphericity indexGCST902684020.01
7099NAGK levelsGCST904699950.01
7100AHCY levelsGCST904682590.01
7101wg lh intensity-contrast lingualGCST900038040.01
7102IGF1 levelsGCST904680780.01
7103CDH1/CDH17 ratioGCST903139450.01
7104Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T179ECGA0001790.01
7105Chronic hepatitis B infectionGCST900185840.01
7106CD209/GP2 ratioGCST903137510.01
7107IDP dMRI TBSS FA Tapetum LGCST900039240.01
7108PIK3AP1/PSMG3 ratioGCST903156510.01
7109Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T473ECGU0004730.01
7110Phosphatidylcholines levels (UKB data field 23437)GCST902695340.01
7111Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T475ECGU0004750.01
7112CX3CL1 levelsGCST900120740.01
7113HSPB1 levelsGCST904694890.01
7114ENG/TNFSF10 ratioGCST903146510.01
7115height (mean, inv-normal transformed)GCST904753620.01
7116T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 86)GCST903209050.01
7117IDP dMRI TBSS FA Retrolenticular part of internal capsule RGCST900038970.01
7118Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T31ECGA0000311.00e-02
7119high density lipoprotein cholesterol (HDLC, minimm, inv-norm transformed)GCST904753541.00e-02
7120FADD/LACTB2 ratioGCST903147679.99e-03
7121Degeneration of macula and posterior pole of retina (PheCode 362.2)GCST904758499.96e-03
7122Pilonidal cystFING000011679.95e-03
7123Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T141ECGU0001419.95e-03
7124aparc-DKTatlas lh volume precentralGCST900028849.94e-03
7125Phospholipids to total lipids ratio in large LDLGCST900928659.94e-03
7126Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T476ECGU0004769.93e-03
7127DiabetesGCST904681249.92e-03
7128Endometriosis ASRM stages 3,4FING000004989.91e-03
7129NFE2 levelsGCST904700359.90e-03
7130Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T8ECGA0000089.89e-03
7131NXF1 levelsGCST902421499.88e-03
7132GNE levelsGCST904693709.88e-03
7133Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T276ECGA0002769.88e-03
7134Triglycerides in large LDL (UKB data field 23536)GCST902696339.87e-03
7135Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T274ECGU0002749.87e-03
7136IDP dMRI ProbtrackX L3 cst rGCST900043099.85e-03
7137COL6A3/NBL1 ratioGCST903141769.85e-03
7138Valvular heart disease excluding rheumatic feverFING000014149.84e-03
7139Glycosyl ceramide (d18:1/20:0, d16:1/22:0) levelsGCST902001459.84e-03
7140Saturated fatty acids levels (UKB data field 23448)GCST902695459.83e-03
7141FABP1/FABP2 ratioGCST903147509.83e-03
7142RNF149 levelsGCST904704829.82e-03
7143Angina pectorisGCST900185739.82e-03
7144PLIN1 levelsGCST904702589.81e-03
7145Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T169ECGA0001699.81e-03
7146Facial pigmentation measurement (polar light)GCST900022849.79e-03
7147SpermatoceleFING000013199.79e-03
7148Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T183ECGU0001839.79e-03
7149TALDO1 levelsGCST904708029.78e-03
7150Lumbar disc prolapseFING000007359.76e-03
7151Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T493ECGA0004939.75e-03
7152Multi-trait sex scoreGCST902701189.74e-03
7153Plasma succinylcarnitine (C4-DC) levels in chronic kidney diseaseGCST902659989.74e-03
7154PGR levelsGCST904702239.74e-03
7155CD40LG/TRAF2 ratioGCST903138289.72e-03
7156Fractured bone site(s) - Wrist | Medical conditionsUKBB000002579.70e-03
7157mean corpuscular volume (MCV, minimum, inv-norm transformed)GCST904754749.69e-03
7158Colon cancer/rectal cancerGCST904751709.68e-03
7159IDP dMRI ProbtrackX FA ar rGCST900039269.67e-03
7160X-12510--2-aminooctanoic acid levelsGCST902437489.67e-03
7161Percentage of fucosylated structures (with bisecting GlcNAc) in total neutral plasma glycans (GP80)GCST906687589.66e-03
7162Physical decline (log-difference score)GCST905658479.65e-03
7163Pulse pressureGCST904727849.65e-03
7164NTF4 levelsGCST904700959.65e-03
7165Other and unspecified tonsillitisFING000009549.64e-03
7166CD7 levelsGCST904686499.64e-03
7167Heart rate variability traits (RMSSD)GCST0047339.64e-03
7168Vascular/heart problems diagnosed by doctor - Heart attack | Medical conditionsUKBB000008979.63e-03
7169CAPS levelsGCST904685399.57e-03
7170Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T135ECGU0001359.57e-03
7171Other disorders of corneaFING000010229.57e-03
7172ERBIN/SIRT2 ratioGCST903146969.56e-03
7173Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor - None of the above | Medical conditionsUKBB000001019.56e-03
7174GOLM2/STC1 ratioGCST903149529.55e-03
7175Phospholipid levels in very small VLDLGCST901326599.55e-03
7176Total cholesterol levelsGCST902396759.53e-03
7177Alkaline phosphatase (UKB data field 30610)GCST904680609.53e-03
7178Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T277ECGA0002779.50e-03
7179CDH1 levelsGCST904686709.49e-03
7180AIFM1/SIRT2 ratioGCST903132219.48e-03
7181IDP dMRI TBSS L1 Body of corpus callosumGCST900040789.46e-03
7182wg lh intensity-contrast superiortemporalGCST900038219.46e-03
7183Operation code - pilonidal sinus surgery (anal) | OperationsUKBB000005639.43e-03
7184AOC3/ITGB1 ratioGCST903132959.42e-03
7185Hallux rigidusFING000006009.42e-03
7186SPARC/TACC3 ratioGCST903158729.40e-03
7187Height (maximum, inv-normal transformed)GCST904753599.39e-03
7188Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T496ECGA0004969.39e-03
7189ISM1 levelsGCST904696309.38e-03
7190Diacylglycerol (18:0_18:1) levelsGCST900247149.34e-03
7191Other diseases of upper respiratory tractFING000010129.33e-03
7192PTH levelsGCST904703729.33e-03
7193Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T81ECGU0000819.32e-03
7194CELA3A/CPB1 ratioGCST903140109.31e-03
7195PLAUR/TREM2 ratioGCST903156769.30e-03
7196Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T48ECGA0000489.30e-03
7197LSP1/NADK ratioGCST903153319.27e-03
7198TGFB1 levelsGCST904708439.26e-03
7199Spleen iron concentrationGCST901018319.26e-03
7200Dimethylglycine levelsGCST902004249.25e-03
7201Statin medicationFING000013319.24e-03
7202Hammer toe (acquired) (PheCode 735.21)GCST904762509.24e-03
7203ANG/F9 ratioGCST903132599.23e-03
7204What is your height? (cm, inv-normal transformed)GCST904753689.21e-03
7205ASGR1/DCBLD2 ratioGCST903133649.20e-03
7206Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T19ECGA0000199.20e-03
7207CCN3 levelsGCST902424929.20e-03
7208rfMRI connectivity (ICA100 edge 951)GCST900058049.19e-03
7209Acute peritonitisFING000000289.18e-03
72105alpha-androstan-3beta,17beta-diol monosulfate (2) levelsGCST901998559.18e-03
7211Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T248ECGA0002489.16e-03
7212LGALS4/TIE1 ratioGCST903153169.15e-03
7213Other arthritis (FG)FING000009649.14e-03
7214GNLY/GZMA ratioGCST903149499.13e-03
7215Phosphate levelsGCST902003939.09e-03
7216TNFRSF19 levelsGCST904709099.08e-03
7217DBNL/HEXIM1 ratioGCST903144179.07e-03
7218Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T7ECGA0000079.05e-03
7219T1 FreeSurfer BA lh BA2 exvivo volumeGCST903855349.04e-03
7220Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T46ECGA0000469.04e-03
7221Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T45ECGA0000459.04e-03
7222Operation code - cholecystectomy/gall bladder removal | OperationsUKBB000005549.03e-03
7223UBE2L6 levelsGCST904710019.03e-03
7224KIFBP/TBC1D23 ratioGCST903152509.02e-03
7225CPA2/ITGB7 ratioGCST903142079.02e-03
7226PAMR1 levelsGCST904701559.01e-03
7227Urine taurocholenate sulfate* levels in chronic kidney diseaseGCST902660419.01e-03
7228Appendicular lean massGCST900000269.01e-03
7229Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T49ECGA0000499.00e-03
72302,3-dihydroxy-5-methylthio-4-pentenoate (dmtpa) levelsGCST902002338.99e-03
7231lymphocyte (absolute count, maximum, inv-norm transformed)GCST904754238.97e-03
7232TNC levelsGCST904708958.95e-03
7233Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T262ECGU0002628.95e-03
7234RET levelsGCST904704588.94e-03
7235CA13/TIA1 ratioGCST903135678.93e-03
7236Waist circumference adjusted for body mass indexGCST903028928.93e-03
7237Androstenediol (3beta,17beta) disulfate (1) levelsGCST901998428.91e-03
7238aparc-DKTatlas lh volume rostralmiddlefrontalGCST900028878.91e-03
7239FKBP5/ZBTB16 ratioGCST903148508.91e-03
7240Seminoma of testis, excluding all cancers (controls excluding all cancers)FING000012898.90e-03
7241T1 FreeSurfer DK rh lingual areaGCST903857018.88e-03
7242SDHB levelsGCST904705618.88e-03
7243BCAM/ICAM4 ratioGCST903134728.87e-03
7244Free cholesterol in small LDLGCST904996178.87e-03
7245Takes medication for enlarged prostate (Benign prostatic hyperplasia)?GCST904752628.86e-03
7246CRISP2 levelsGCST904688658.86e-03
7247X-26109 levelsGCST902006718.85e-03
7248ERBIN/LYN ratioGCST903146948.85e-03
7249Triglyceride levels in very small VLDLGCST901326698.84e-03
7250Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)FING000007708.83e-03
7251CLEC4G/LGALS4 ratioGCST903141208.83e-03
7252VSTM2B levelsGCST904710568.82e-03
7253Cholesterol levels in very large VLDLGCST905005188.82e-03
7254Polyunsaturated fatty acids to total fatty acids percentageGCST905021738.81e-03
7255Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T152ECGU0001528.81e-03
7256Eye conditions (confirmatory factor analysis Factor 25)GCST903093598.80e-03
7257Free Cholesterol to Total Lipids in Medium HDL percentageGCST904985838.78e-03
7258SEL1L levelsGCST904705648.77e-03
7259Pulse pressureGCST904727838.77e-03
7260Takes medication for Glaucoma?GCST904753848.76e-03
7261Left ventricular outflow tract obstruction, narrow definitionFING000007188.73e-03
7262T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 4)GCST903208238.72e-03
7263MYBPC1 levelsGCST904699698.72e-03
7264CERT/PRTFDC1 ratioGCST903140298.71e-03
7265IDO1 levelsGCST902414908.71e-03
7266MCEE levelsGCST904698718.70e-03
7267Effects radiation NOS (PheCode 990)GCST904762938.70e-03
7268Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T131ECGA0001318.69e-03
7269QDPR levelsGCST904704008.69e-03
7270DTI autoptx L3 ifo r tractGCST903852068.69e-03
7271ASGR1 levelsGCST904683758.68e-03
7272Deaf mutism, not elsewhere classifiedFING000003788.67e-03
7273PAEP/RSPO1 ratioGCST903155938.65e-03
7274TREM2 levelsGCST904709608.65e-03
7275Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T217ECGU0002178.63e-03
7276IDP dMRI TBSS MD Pontine crossing tractGCST900040288.63e-03
7277Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T147ECGU0001478.63e-03
7278GRHPR levelsGCST904694008.62e-03
72792s,3R-dihydroxybutyrate levelsGCST901998828.62e-03
7280VWC2 levelsGCST904710648.62e-03
7281SERPINB13 levelsGCST904233268.62e-03
7282Biological Grandparent (paternal): Diabetes / SugarGCST904755498.60e-03
7283Serum 25-Hydroxyvitamin D levelsGCST900006148.59e-03
7284CAPN3 levelsGCST904685388.59e-03
7285Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T137ECGA0001378.57e-03
7286Lysoalkylphosphatidylcholine (O-24:1) levelsGCST900248138.56e-03
7287FKBP4/SIRT2 ratioGCST903148418.53e-03
7288CXCL9 levelsGCST902747848.53e-03
7289Plasma propionylcarnitine (C3) levels in chronic kidney diseaseGCST902658768.51e-03
7290T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 23)GCST903208428.51e-03
7291CD164/PARK7 ratioGCST903137438.50e-03
7292Volume of right anterior amygdaloid areaGCST904750008.47e-03
7293Mean reticulocyte volume | Blood countUKBB000004518.44e-03
7294Fasciitis (PheCode 728.7)GCST904762448.42e-03
7295CRTAM/TNFRSF9 ratioGCST903142808.41e-03
7296chloride (maximum, inv-norm transformed)GCST904751928.40e-03
7297Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T214ECGA0002148.38e-03
7298C4BPB levelsGCST904684998.38e-03
7299Meniscus derangementFING000008078.38e-03
7300Phosphatidylcholine_34:3_[M+H]1+/Phosphatidylethanolamine_37:3_[M+H]1+/Phosphatidate_39:4_[M+NH4]1+ levelsGCST900602988.37e-03
7301IL6ST/PDGFRA ratioGCST903151698.36e-03
7302HAVCR2/TREM2 ratioGCST903150318.36e-03
7303IDP dMRI TBSS MD Uncinate fasciculus RGCST900040718.35e-03
7304TXN levelsGCST904709958.34e-03
7305MMP10 levelsGCST900120508.33e-03
7306Non-seminoma of testis, excluding all cancers (controls excluding all cancers)FING000008748.33e-03
7307ARHGAP30 levelsGCST904683548.33e-03
7308Esophageal adenocarcinomaGCST0037398.32e-03
7309Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T27ECGA0000278.30e-03
7310CCL17/PDGFB ratioGCST903136888.28e-03
7311SPINK1 levelsGCST904707218.27e-03
7312Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T173ECGA0001738.25e-03
7313Mean reticulocyte volume (UKB data field 30260)GCST904680888.23e-03
7314Wegener granulomatosisFING000014468.23e-03
7315Major coronary heart disease eventFING000007468.22e-03
7316SCARA5/SCARF2 ratioGCST903158088.21e-03
7317IDP dMRI ProbtrackX ISOVF unc lGCST900045508.21e-03
7318Selective deficiency of immunoglobulin G [IgG] subclassesFING000012888.19e-03
7319Creatinine levelsGCST900259468.19e-03
7320CA5A/GSTA1 ratioGCST903135918.19e-03
7321Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T264ECGA0002648.16e-03
7322Skin cancer | neoplasmsUKBB000007728.16e-03
7323GM1 ganglioside (d18:1/16:0) levelsGCST900247248.15e-03
7324Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T177ECGA0001778.14e-03
7325Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T477ECGU0004778.13e-03
7326PEAR1 levelsGCST904702048.11e-03
7327Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T178ECGA0001788.11e-03
7328DAG1/MGLL ratioGCST903143778.11e-03
7329ABL1/CC2D1A ratioGCST903131488.11e-03
7330DTI TBSS MD Superior corona radiata LGCST903845978.10e-03
7331X-12844 levelsGCST902005238.10e-03
7332T1 FreeSurfer pial rh posteriorcingulate areaGCST903858448.10e-03
7333HBB levelsGCST900259698.10e-03
7334Concentration of HDL particles (UKB data field 23430)GCST902695278.10e-03
7335Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T249ECGA0002498.10e-03
7336PEAR1/SCARF1 ratioGCST903156428.08e-03
7337ADAM23 levelsGCST904682198.07e-03
7338Diverticular disease of intestine | Other diseases of intestinesUKBB000001898.07e-03
7339DTI TBSS L2 Anterior corona radiata RGCST903844988.04e-03
7340Pulse pressureGCST903102968.03e-03
7341Triglycerides in small LDLGCST904997128.02e-03
7342JAM2/TNFRSF14 ratioGCST903152408.00e-03
7343GGT1 levelsGCST904693368.00e-03
7344FABP9 levelsGCST904691797.98e-03
7345FAM3B/GUCA2A ratioGCST903147797.98e-03
7346IDP dMRI ProbtrackX OD str lGCST900044737.98e-03
7347Volume of left central nucleusGCST904748837.97e-03
7348B4GALT1/B4GAT1 ratioGCST903134297.97e-03
7349Indolebutyrate levelsGCST901997597.97e-03
7350GLOD4/MIF ratioGCST903149397.96e-03
7351T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 54)GCST903206177.96e-03
7352KITLG levelsGCST900120237.95e-03
7353Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T261ECGU0002617.95e-03
7354IGSF9 levelsGCST904695417.95e-03
7355Eosinophil percentage of granulocytesGCST0046177.94e-03
7356Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T148ECGA0001487.92e-03
7357AP1G2 levelsGCST904683237.92e-03
7358SIRPA levelsGCST904706397.92e-03
7359Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T206ECGA0002067.92e-03
7360CCL17/THPO ratioGCST903136897.91e-03
7361Chronic obstructive pulmonary disease x ever smoker interaction (main effect)GCST900165867.91e-03
7362Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T469ECGU0004697.90e-03
7363T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 78)GCST903208977.89e-03
7364NCR1 levelsGCST900901537.87e-03
7365CDH2/CDHR2 ratioGCST903139507.83e-03
7366Plasma pregnenetriol disulfate* levels in chronic kidney diseaseGCST902658647.82e-03
7367Prescriptions - doxazosin | alpha1-antagonist,alpha blockerUKBB000006797.79e-03
7368VTI1A levelsGCST904710607.78e-03
7369Excessive vomiting in pregnancyFING000005237.77e-03
7370wg lh intensity-contrast pericalcarineGCST900038127.75e-03
7371T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 33)GCST903205967.75e-03
7372VGF levelsGCST904710387.73e-03
7373Lysophosphatidylcholine (24:0) [sn2] levelsGCST900241877.71e-03
7374AIFM1/EGF ratioGCST903132197.68e-03
7375Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T21ECGU0000217.68e-03
7376RILP/RWDD1 ratioGCST903157787.66e-03
7377SIGLEC8 levelsGCST900898867.65e-03
7378Nasal polypsGCST904681437.64e-03
7379Hypertrophic scarFING000006427.62e-03
7380EGFR/MEGF9 ratioGCST903146147.61e-03
7381Thyrotoxicosis with diffuse goitreFING000013617.60e-03
7382APBB1IP/POLR2F ratioGCST903133007.60e-03
7383IDP dMRI TBSS ISOVF Cingulum cingulate gyrus RGCST900045117.60e-03
7384Creatinine levels in bottom 99% of individuals by creatinine levelsGCST905667337.59e-03
7385Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T152ECGA0001527.57e-03
7386FKBP4 levelsGCST904692437.57e-03
7387Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T274ECGA0002747.56e-03
7388AmygNuclei lh volume Central-nucleusGCST900026527.56e-03
7389Triglycerides in LDL (UKB data field 23409)GCST902695067.56e-03
7390Operative procedures - Endoscopic resection of semilunar cartilage NEC | Summary OperationsUKBB000005777.56e-03
7391X-12063 levelsGCST902436877.55e-03
7392CLMP/GFRA1 ratioGCST903141337.55e-03
7393Propionylglycine levelsGCST901997057.54e-03
7394Omega-6 fatty acids levels (UKB data field 23445)GCST902695427.53e-03
7395IL15/NCR1 ratioGCST903151507.53e-03
7396CTSL levelsGCST904689147.53e-03
7397Other disorders of eye and adnexaFING000010257.53e-03
7398TMPRSS15 levelsGCST904708927.52e-03
7399SMPD1/SMPDL3A ratioGCST903158547.51e-03
7400Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T14ECGA0000147.51e-03
7401LCN2/PRTN3 ratioGCST903153077.51e-03
7402VLDL cholesterol levelsGCST905001897.49e-03
7403PRKG1 levelsGCST904703307.49e-03
7404IDP dMRI TBSS L1 Corticospinal tract RGCST900040817.49e-03
7405Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T213ECGA0002137.49e-03
7406IL5RA levelsGCST904696007.49e-03
7407Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T20ECGU0000207.48e-03
7408T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 121)GCST903206847.46e-03
7409CX3CL1/DSG2 ratioGCST903143237.46e-03
7410SERPINE1/SPARC ratioGCST903158347.46e-03
7411Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T142ECGU0001427.45e-03
7412aparc-Desikan rh volume fusiformGCST900028077.44e-03
7413EDAR/PSRC1 ratioGCST903145847.42e-03
7414Neutrophil countGCST900187487.42e-03
7415CGREF1/FAM3C ratioGCST903140327.42e-03
7416Operation code - haemorroidectomy / piles surgery/ banding of piles | OperationsUKBB000005577.42e-03
7417Triglyceride levels in chylomicrons and extremely large VLDLGCST905010687.41e-03
7418Polymyalgia rheumaticaFING000011887.40e-03
7419Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T184ECGA0001847.40e-03
7420DAPK2 levelsGCST904689457.38e-03
7421Diastolic blood pressure (BMI adjusted)GCST903351657.38e-03
7422Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T230ECGU0002307.37e-03
7423T1 FreeSurfer aseg 3rd-VentricleGCST903841477.36e-03
7424creatinine (mean, inv-norm transformed)GCST904752297.36e-03
7425Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T80ECGU0000807.36e-03
7426chloride (mean, inv-norm transformed)GCST904751947.36e-03
7427FAS levelsGCST900907017.35e-03
7428Zoster infectionGCST900187217.35e-03
7429Breast cancerGCST904298467.33e-03
7430RASSF2 levelsGCST904704317.32e-03
7431CRYBB1 levelsGCST904688747.31e-03
7432DNAJB1/SIRT2 ratioGCST903145117.31e-03
7433Birth weight | Early life factorsUKBB000000957.31e-03
7434estimated glomerular filtration rate (eGFR, minimum, inv-norm transformed)GCST904752857.29e-03
7435Mean reticulocyte volumeGCST900023967.28e-03
7436Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T180ECGA0001807.27e-03
7437Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T11ECGU0000117.27e-03
7438height (minimum, inv-normal transformed)GCST904753657.27e-03
7439Triacylglycerol_45:4_[M+NH4]1+ levelsGCST900603337.26e-03
7440Calculus of kidney and ureterFING000002367.26e-03
7441C5 levelsGCST904685007.26e-03
7442Mixed conductive and sensorineural hearing lossFING000008277.25e-03
7443wg rh intensity-contrast insulaGCST900038617.23e-03
7444IRF2 levelsGCST902415667.20e-03
7445T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 125)GCST903206887.19e-03
7446Total fatty acids levels (UKB data field 23442)GCST902695397.19e-03
7447Cancer (standard GWA)GCST902672707.19e-03
7448COL18A1/RETN ratioGCST903141707.18e-03
7449HSPA1A/MGLL ratioGCST903150837.18e-03
7450Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T185ECGA0001857.18e-03
7451Migraine without aura and triptan purchasesFING000008227.17e-03
7452Torso length to body height ratioGCST902702627.16e-03
7453HSPG2 levelsGCST901793927.15e-03
7454HLA-DMA levelsGCST902414487.15e-03
7455Eicosenoylcarnitine (C20:1) levelsGCST902001487.14e-03
7456FXYD5/TMSB10 ratioGCST903149067.14e-03
7457GoutGCST903997007.14e-03
7458wg rh intensity-contrast medialorbitofrontalGCST900038407.13e-03
7459ESAM/TGFB1 ratioGCST903147187.10e-03
7460Phosphatidylcholine-O_40:6_[M+H]1+/Phosphatidylcholine-P_40:5_[M+H]1+ levelsGCST900604207.09e-03
7461Gouty arthropathy (PheCode 274.11)GCST904757387.09e-03
7462Aplastic anemia (PheCode 284)GCST904757837.08e-03
7463Eye problems/disorders - Glaucoma | EyesightUKBB000002317.08e-03
7464rfMRI connectivity (ICA100 edge 399)GCST900052527.05e-03
7465CD58/LTBR ratioGCST903138517.04e-03
7466Unstable angina pectorisFING000014057.04e-03
7467Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T18ECGA0000187.03e-03
7468CES2 levelsGCST904687197.02e-03
7469Monounsaturated fatty acid levelsGCST905023637.02e-03
7470Prostate cancerGCST904751857.00e-03
7471CNTN1/EGFR ratioGCST903141627.00e-03
7472estimated glomerular filtration rate (eGFR, mean, inv-norm transformed)GCST904752827.00e-03
7473CD4/LILRB4 ratioGCST903138436.99e-03
7474Massiliomicrobiota abundance in stoolGCST900324706.98e-03
7475aparc-Desikan lh area fusiformGCST900030796.98e-03
7476Lung function (FVC)GCST900259986.97e-03
7477BCAN/MOG ratioGCST903134806.97e-03
7478Atopic dermatitisGCST900185646.97e-03
7479IFNGR1 levelsGCST904695136.97e-03
7480SLC39A14 levelsGCST904706606.97e-03
7481T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 58)GCST903206216.96e-03
7482Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T263ECGA0002636.95e-03
7483CKMB levelsGCST904752216.92e-03
7484PLA2G15 levelsGCST904702456.89e-03
7485BMP7 levelsGCST900881576.89e-03
7486T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 65)GCST903206286.89e-03
7487Central corneal thicknessGCST0063666.87e-03
7488YWHAQ levelsGCST904710926.87e-03
7489APCS levelsGCST904683286.87e-03
7490X-08402 levelsGCST902435386.86e-03
7491aparc-a2009s rh volume G-precentralGCST900030276.86e-03
7492TFPI levelsGCST904708396.86e-03
7493Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T256ECGA0002566.86e-03
7494HNRNPK/USP8 ratioGCST903150706.85e-03
7495KITLG levelsGCST902748336.84e-03
7496Cancer of bronchus; lung (PheCode 165.1)GCST904755736.83e-03
7497HippSubfield rh volume CA3-headGCST900027076.82e-03
7498CD79B/FCRL2 ratioGCST903139006.82e-03
7499IDP SWI T2star right caudateGCST900038666.81e-03
7500Lateral epicondylitisFING000007156.80e-03
7501IDP dMRI ProbtrackX L2 ar rGCST900042746.80e-03
7502Thyroid cancer (PheCode 193)GCST904756006.79e-03
7503Nontoxic nodular goiter (PheCode 241)GCST904756386.79e-03
7504NAP1L4 levelsGCST904699986.78e-03
7505Autoimmune diseases excluding thyroid diseasesFING000001326.78e-03
7506ARHGAP25 levelsGCST902426516.78e-03
7507CEACAM8/RNASE3 ratioGCST903140046.78e-03
7508SORD levelsGCST904707096.77e-03
75091-stearoyl-2-docosahexaenoyl-gpc (18:0/22:6) levelsGCST902000466.77e-03
7510CEACAM20 levelsGCST904686936.77e-03
7511TARBP2 levelsGCST904708056.77e-03
7512Creatinine | Blood biochemistryUKBB000001566.74e-03
7513Total Lipids in HDLGCST904974016.74e-03
7514CCL19 levelsGCST902747656.73e-03
7515Diabetes (confirmatory factor analysis Factor 28)GCST903093626.73e-03
7516Hearing difficultyGCST902457746.73e-03
7517Prescriptions - thyroid hormone | hormoneUKBB000007056.73e-03
7518Prescriptions - levothyroxine | thyroid hormoneUKBB000006876.72e-03
7519CBLN4/RET ratioGCST903136606.71e-03
7520IFIT2 levelsGCST900908646.70e-03
7521Estimated glomerular filtration rate (creatinine, cystatin c)GCST904284466.68e-03
7522Other intervertebral disc disordersFING000010636.65e-03
7523aparc-DKTatlas lh volume cuneusGCST900028656.63e-03
7524Left-hemisphere salience/ventral attention network to pallidum white-matter structural connectivityGCST903027226.62e-03
7525Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T136ECGA0001366.61e-03
7526CKAP2 levelsGCST902408666.61e-03
7527HematocritGCST900023056.60e-03
7528CDH5/PEAR1 ratioGCST903139596.58e-03
7529EPS8L2/LGALS4 ratioGCST903146856.58e-03
7530Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T132ECGA0001326.57e-03
7531CST3 levelsGCST904688946.55e-03
7532wg lh intensity-contrast parahippocampalGCST900038076.55e-03
7533NHLRC3 levelsGCST904700466.52e-03
7534HPCAL1/SERPINB9 ratioGCST903150796.51e-03
7535Left ventricular end diastole anterospetal wall thicknessGCST902785196.51e-03
7536DTI TBSS FA Anterior corona radiata LGCST903844036.50e-03
7537aparc-pial lh area pericalcarineGCST900031616.48e-03
7538Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T51ECGA0000516.48e-03
7539APOB/APOA1 ratioGCST902695386.48e-03
7540MICB or MICA levelsGCST904699056.46e-03
7541Operation code - anterior/posterior repair bladder/uterus | OperationsUKBB000005486.46e-03
7542N-acetylmethionine levelsGCST902002896.46e-03
7543Gestational diabetes mellitusGCST905664196.46e-03
7544Ovarian dysfunctionFING000011336.45e-03
7545APOA1 levelsGCST904971196.44e-03
7546Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T278ECGA0002786.44e-03
7547Serum 25-Hydroxyvitamin D levelsGCST900006186.43e-03
7548CASP7 levelsGCST904685476.43e-03
7549PDGF-BB levelsGCST904284306.42e-03
7550Intrahepatic cholestasis of pregnancyGCST904541996.40e-03
7551Systemic lupus erythematosusGCST900118666.39e-03
7552Concentration of medium VLDL particlesGCST904990176.39e-03
7553IDP dMRI TBSS L1 Posterior corona radiata LGCST900041026.39e-03
7554Phospholipids to Total Lipids in Medium VLDL percentageGCST904990446.39e-03
7555ENG/PEAR1 ratioGCST903146496.39e-03
7556Perforation of tympanic membraneFING000011556.37e-03
7557AnginaGCST904681096.36e-03
7558KLK15 levelsGCST904697016.35e-03
7559EPHB6/VWC2 ratioGCST903146836.34e-03
7560Retinal arteriolar widthGCST902703986.34e-03
7561CTSZ/HSPG2 ratioGCST903143186.34e-03
7562HippSubfield lh volume GC-ML-DG-headGCST900026796.33e-03
7563Rheumatoid arthritisGCST901322246.33e-03
7564Oral glucose tolerance test-2hGCST902977906.33e-03
7565Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T50ECGA0000506.29e-03
7566FYB1/PPP1R12A ratioGCST903149136.28e-03
7567MANF/PTPN6 ratioGCST903153666.27e-03
7568FST levelsGCST900120806.27e-03
7569Right-hemisphere somatomotor network to right-hemisphere somatomotor network white-matter structural connectivityGCST903027886.27e-03
7570AXL/IL18BP ratioGCST903134206.27e-03
7571S100A11/S100A12 ratioGCST903157986.26e-03
7572CDH6/NTRK2 ratioGCST903139626.26e-03
7573CEACAM1 levelsGCST904686926.25e-03
7574Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T153ECGA0001536.25e-03
7575aparc-DKTatlas rh volume fusiformGCST900028986.24e-03
7576CTRC/KIRREL2 ratioGCST903143096.23e-03
7577Total fatty acid levelsGCST905022206.23e-03
7578CDCP1/IL18BP ratioGCST903139376.23e-03
7579SEPTIN8 levelsGCST904705786.21e-03
7580Polyunsaturated fatty acids to saturated fatty acids ratioGCST905021606.21e-03
7581Plasma taurocholenate sulfate* levels in chronic kidney diseaseGCST902660406.21e-03
7582CD2AP levelsGCST904686176.20e-03
7583Volume of left whole amygdalaGCST904748986.18e-03
7584MAP2K6/MGMT ratioGCST903153736.18e-03
7585MAP4K5/STAMBP ratioGCST903153826.16e-03
7586Phospholipids in HDLGCST904974306.15e-03
7587Free cholesterol in large LDLGCST904979876.15e-03
7588aparc-Desikan lh area parstriangularisGCST900030926.14e-03
7589F2R/TNFRSF14 ratioGCST903147396.14e-03
7590DTI autoptx L2 ilf r tractGCST903851816.14e-03
7591Cerebral aneurysm, nonrupturedFING000002636.13e-03
7592PADI2 levelsGCST904701426.12e-03
7593Left-hemisphere visual network to right-hemisphere visual network white-matter structural connectivityGCST903026556.12e-03
7594Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T30ECGA0000306.11e-03
7595Polyunsaturated fatty acids levels (UKB data field 23446)GCST902695436.11e-03
7596DiverticulitisGCST904681256.11e-03
7597Volume of left paralaminar nucleusGCST904749856.10e-03
7598Congenital lactase deficiencyFING000003296.10e-03
7599Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T4ECGA0000046.10e-03
7600CALCOCO1/VPS53 ratioGCST903136126.09e-03
7601PPCDC levelsGCST904702906.09e-03
7602CAMKK1/FOXO1 ratioGCST903136136.07e-03
7603AZU1/RNASE3 ratioGCST903134286.06e-03
7604MED18/TACC3 ratioGCST903154146.06e-03
7605Cholesteryl Esters in Medium HDLGCST904985386.06e-03
7606DNAJB14 levelsGCST902409526.05e-03
7607REST UKBBICA NODEamps25 0021GCST903855046.05e-03
7608Linoleic acid levelsGCST905020106.03e-03
7609IDO1 levelsGCST904695066.02e-03
7610CEACAM8/MMP9 ratioGCST903140026.02e-03
7611Treatment/medication code - ibuprofen | MedicationsUKBB000008476.01e-03
7612rfMRI connectivity (ICA100 edge 380)GCST900052336.01e-03
7613DTI autoptx L2 ilf l tractGCST903851806.00e-03
7614Migraine without auraFING000008216.00e-03
7615wg rh intensity-contrast lingualGCST900038395.99e-03
7616Thyroid stimulating hormone levelsGCST903193215.96e-03
7617Corneal resistance factor (right) | Intraocular pressureUKBB000001515.96e-03
7618BMPER levelsGCST904684555.95e-03
7619Chronic obstructive pulmonary disease in never smokersGCST900165895.95e-03
7620Left-hemisphere visual network to thalamus white-matter structural connectivityGCST903026625.95e-03
7621DKKL1 levelsGCST904690005.94e-03
7622wg rh intensity-contrast middletemporalGCST900038415.92e-03
7623Humerus length to body height ratioGCST902702595.92e-03
7624HVEM on Terminally Differentiated CD4+ T cellGCST900018795.91e-03
7625Arthropathy in ulcerative colitisFING000001105.90e-03
7626VEGFD levelsGCST904710375.90e-03
7627CD40LG/TNFSF14 ratioGCST903138275.90e-03
7628Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T11ECGA0000115.90e-03
7629IDP dMRI ProbtrackX ISOVF ar rGCST900045265.90e-03
7630Glaucoma | sense organsUKBB000002875.89e-03
7631CTSO levelsGCST904689155.89e-03
7632Phosphatidylcholine levelsGCST900929375.89e-03
7633Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T172ECGA0001725.89e-03
7634IDP T1 FAST ROIs L intracalc cortexGCST900024975.88e-03
7635MECR levelsGCST904698795.88e-03
7636Basal metabolic rate (UKB data field 23105)GCST904681595.87e-03
7637N-acetyltaurine levelsGCST901999675.87e-03
7638MITD1/SNX9 ratioGCST903154545.87e-03
7639ACOT13 levelsGCST904682005.87e-03
7640Volume of left medial nucleusGCST904749765.85e-03
7641Total fatty acid levelsGCST905000535.84e-03
7642Operation code - inguinal/femoral hernia repair | OperationsUKBB000005615.84e-03
7643Malignant neoplasm of bronchus and lung, excluding all cancers (controls excluding all cancers)FING000007565.84e-03
7644Other aneurysm (PheCode 442)GCST904759925.82e-03
7645MMP8/TGFA ratioGCST903154665.80e-03
7646ADGRD1 levelsGCST904682355.80e-03
7647CXCL9 levelsGCST904689355.80e-03
7648Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T185ECGU0001855.79e-03
7649EDIL3 levelsGCST904690725.79e-03
7650Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T181ECGA0001815.78e-03
7651PLA2G4A/PPP1R12A ratioGCST903156665.77e-03
7652Heart failure with reduced EF [Systolic or combined heart failure] (PheCode 428.3)GCST904759835.77e-03
7653EGF/TNFSF14 ratioGCST903146155.77e-03
7654aseg lh number HolesBeforeFixingGCST900026305.77e-03
7655CTRB1/KIRREL2 ratioGCST903143065.76e-03
7656Carnitine levelsGCST901996215.74e-03
7657Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T83ECGA0000835.73e-03
7658HematocritGCST900187405.73e-03
7659Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T76ECGA0000765.73e-03
7660CLEC4D/TGFA ratioGCST903141175.71e-03
7661aparc-a2009s lh volume S-precentral-sup-partGCST900029935.71e-03
7662IDP dMRI TBSS L1 Anterior corona radiata LGCST900040985.71e-03
7663Microscopic polyangiitisFING000008175.71e-03
7664DTI TBSS L2 Superior cerebellar peduncle RGCST903844885.70e-03
7665Maximum indexed left atrial volumeGCST900190125.69e-03
7666IDP dMRI TBSS L1 Superior corona radiata RGCST900040995.69e-03
7667aparc-Desikan lh volume precentralGCST900027915.69e-03
7668IGBP1 levelsGCST904695215.68e-03
7669DBH levelsGCST904689485.68e-03
7670Corneal hysteresis (right) | Intraocular pressureUKBB000001495.67e-03
7671CHI3L1/PRSS8 ratioGCST903140445.65e-03
7672CST3 levelsUKBB000001635.63e-03
7673Total body bone mineral density (age 0-15)GCST0053455.63e-03
7674DKK1/VEGFC ratioGCST903144845.63e-03
7675Adenocarcinoma and papilloma adenocarcinoma of rectumFING000000395.62e-03
7676Breast cancer (triple negative or BRCA1-positive)GCST0101005.62e-03
7677Triglyceride (52:5) levelsGCST904883205.61e-03
7678PGF levelsGCST904702185.60e-03
7679IDP dMRI ProbtrackX OD fmaGCST900044605.60e-03
7680FABP4/SNCG ratioGCST903147595.60e-03
7681APEX1/LSP1 ratioGCST903133075.59e-03
7682USP25 levelsGCST904710195.57e-03
7683Polyunsaturated fatty acids to monounsaturated fatty acids ratioGCST905025715.57e-03
7684PPP1R9B levelsGCST904703055.57e-03
7685Systolic blood pressure, manual reading, adjusted by medication | Cardiovascular measurementUKBB000008125.56e-03
7686T1 FreeSurfer a2009s rh Pole occipital areaGCST903849315.56e-03
7687creatinine (minimum, inv-norm transformed)GCST904752325.56e-03
7688CNST/DOK2 ratioGCST903141575.54e-03
7689CRYBB2 levelsGCST904688755.54e-03
7690Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T183ECGA0001835.54e-03
7691Estimated glomerular filtration rate, serum creatinine | Other measurementUKBB000002125.52e-03
7692Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T186ECGA0001865.51e-03
7693Nonsuppurative otitis mediaFING000008855.51e-03
7694Degree of unsaturationGCST905022335.50e-03
7695aparc-DKTatlas lh area cuneusGCST900032375.50e-03
7696Neoplasm of uncertain behavior of skin (PheCode 173)GCST904755855.50e-03
7697GP6/SCARF1 ratioGCST903149695.50e-03
7698Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T170ECGA0001705.49e-03
7699Monounsaturated fatty acid levelsGCST905020385.49e-03
7700Seborrheic keratosis (PheCode 702.2)GCST904762065.49e-03
7701IGFBP6/SMOC2 ratioGCST903151385.49e-03
7702Alanine levelsGCST904970865.48e-03
7703Behaviour of cancer tumour: malignant, primary site, PHESANT recoding (UKB data field 40012_3)GCST900439465.48e-03
7704Triglyceride to phosphoglyceride ratioGCST904999925.48e-03
7705CC2D1A/STIP1 ratioGCST903136655.47e-03
7706LAYN/VWC2 ratioGCST903152935.47e-03
7707Emphysema (PheCode 496.1)GCST904760285.47e-03
7708Open wound of foot except toe(s) alone (PheCode 871.3)GCST904762865.46e-03
7709T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 76)GCST903208955.45e-03
7710Gout, unspecifiedFING000005895.43e-03
7711Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T260ECGU0002605.43e-03
7712SEMA4D/TREML2 ratioGCST903158235.42e-03
7713CXCL5/PPIB ratioGCST903143525.41e-03
7714creatinine (maximum, inv-norm transformed)GCST904752265.41e-03
7715estimated glomerular filtration rate (eGFR, maximum, inv-norm transformed)GCST904752805.41e-03
7716Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T15ECGA0000155.41e-03
7717Blood cell traits latent factor 18 (platelet)GCST905592605.41e-03
7718aparc-DKTatlas lh thickness cuneusGCST900035435.40e-03
7719IDP T1 FAST ROIs R hippocampusGCST900025565.40e-03
7720Secondary hypertensionFING000012855.39e-03
7721CRHBP/TREM2 ratioGCST903142605.37e-03
7722T1 FreeSurfer DK rh lateraloccipital volumeGCST903857675.36e-03
7723T1 CAT volume R SupramarginalGyrusanteriordivisionGCST903840375.36e-03
7724Creatinine levels (UKB data field 30700)GCST904680675.35e-03
7725Urate | Blood biochemistryUKBB000008845.35e-03
7726AHCY/FABP5 ratioGCST903132085.35e-03
7727Diastolic blood pressure (BMI unadjusted)GCST903351645.34e-03
7728SETMAR levelsGCST904706055.34e-03
7729Trihexosylcermide (d18:1/18:0) levelsGCST900247385.32e-03
7730Total fatty acid levelsGCST905027275.31e-03
7731Acetabular diameterGCST904489065.30e-03
7732HippSubfield lh volume CA4-headGCST900026825.30e-03
7733GP2/SELE ratioGCST903149625.29e-03
7734DNAJB2 levelsGCST904690135.29e-03
7735AGRN levelsGCST904682555.28e-03
7736DTI autoptx L3 ilf r tractGCST903852085.28e-03
7737Diacylglycerol_44:6_[M+H-H2O]1+ levelsGCST900602455.28e-03
7738Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T472ECGU0004725.27e-03
7739Allergic rhinitisFING000000715.26e-03
7740IRAG2 levelsGCST904696265.26e-03
7741TRIM58 levelsGCST904709695.25e-03
7742Right-hemisphere visual network to amygdala white-matter structural connectivityGCST903027865.24e-03
7743CDKN2D/ITGB1BP2 ratioGCST903139875.24e-03
7744GZMB levelsGCST904694245.23e-03
7745aparc-a2009s lh volume S-circular-insula-supGCST900029735.23e-03
7746BA-exvivo lh area V1GCST900032165.23e-03
7747FCRL1/TREML2 ratioGCST903147975.22e-03
7748IDP SWI T2star left caudateGCST900038655.22e-03
7749Serum 25-Hydroxyvitamin D levels (conditioned on BMI)GCST900006165.21e-03
7750KYNU levelsGCST904697225.21e-03
7751BlepharochalasisFING000002205.20e-03
7752Intraocular pressure (confirmatory factor analysis Factor 26)GCST903093605.20e-03
7753NECTIN4/SPINK5 ratioGCST903155345.19e-03
7754KeloidGCST900186545.19e-03
7755Polyunsaturated fatty acids to total fatty acids percentageGCST905021815.19e-03
7756BMP6/SPINT2 ratioGCST903135295.18e-03
7757Nonalcoholic fatty liver diseaseGCST900547825.18e-03
7758Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T119ECGU0001195.18e-03
7759MVK levelsGCST904699675.17e-03
7760Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T146ECGU0001465.15e-03
7761Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T88ECGA0000885.15e-03
7762TNFRSF13B/TNFRSF13C ratioGCST903159315.14e-03
7763Gestational diabetes (for exclusion)FING000005735.13e-03
7764CX3CL1/RGMB ratioGCST903143275.11e-03
7765T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 62)GCST903206255.11e-03
7766APP/EGF ratioGCST903133225.10e-03
7767AGRN/HSPG2 ratioGCST903132015.09e-03
7768Plasma 3-hydroxyhexanoate levels in chronic kidney diseaseGCST902644985.09e-03
7769GZMA/GZMH ratioGCST903150085.09e-03
7770CLIP2/DAB2 ratioGCST903141245.08e-03
7771Psoriasis (vulgaris), strict definitionFING000012235.08e-03
7772T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 77)GCST903208965.08e-03
7773Hyperplasia of prostateFING000006355.08e-03
7774CD46/TNFRSF14 ratioGCST903138385.07e-03
7775CD164/NUDT5 ratioGCST903137425.06e-03
7776DSCAM levelsGCST904690415.06e-03
7777LGALS3 levelsGCST901793035.06e-03
7778ACY1 levelsGCST904682125.05e-03
7779Volume of right medial nucleusGCST904749255.04e-03
7780Pulse pressure, combined automated + manual reading | Cardiovascular measurementUKBB000007185.04e-03
7781Waist-hip ratioGCST902786495.01e-03
7782Colorectal cancer, excluding all cancers (controls excluding all cancers)FING000003175.01e-03
7783HMBS/UBAC1 ratioGCST903150665.01e-03
7784T1 CAT volume R RightThalamusGCST903840975.00e-03
7785Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T20ECGA0000204.99e-03
7786aseg rh intensity Accumbens-areaGCST900037884.99e-03
7787Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T144ECGA0001444.99e-03
7788Diastolic blood pressureGCST900187324.98e-03
7789Squamous cell carcinoma (PheCode 172.22)GCST904755834.98e-03
7790Cerebrospinal fluid unidentified metabolite levels (HILIC Metabolomics ID: 3.04_132.06)GCST902915824.98e-03
7791AK2 levelsGCST904682704.97e-03
7792PAPPA levelsGCST904701574.97e-03
7793DAB2/GRAP2 ratioGCST903143644.96e-03
7794ACY1/GSTA1 ratioGCST903131634.96e-03
7795Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum, excluding all cancers (controls excluding all cancers)FING000000414.95e-03
7796Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T256ECGU0002564.95e-03
7797FGL1 levelsGCST904692354.94e-03
7798Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T148ECGU0001484.94e-03
7799DTI autoptx L2 unc r tractGCST903851924.94e-03
7800Malignant neoplasm of skin, excluding all cancers (controls excluding all cancers)FING000007724.93e-03
7801LILRB4 levelsGCST904267084.92e-03
7802Osteoarthritis of the hip or kneeGCST0070924.92e-03
7803Phospholipids in IDLGCST904976264.92e-03
7804APEX1 levelsGCST904683294.91e-03
7805PRCP/SELE ratioGCST903157264.90e-03
7806aparc-pial rh area fusiformGCST900031804.89e-03
7807eosinophil (absolute count, minimum, inv-norm transformed)GCST904752944.89e-03
7808Pollen allergyFING000011764.86e-03
7809CES1 levelsGCST904687184.86e-03
7810COMT levelsGCST904688284.85e-03
7811Operative procedures - Unspecified diagnostic endoscopic examination of colon | Summary OperationsUKBB000005914.85e-03
7812FAM3B/FGF19 ratioGCST903147764.84e-03
7813Benign neoplasm: Colon, unspecifiedFING000001724.84e-03
7814ALCAM levelsGCST904682794.84e-03
7815Monounsaturated fatty acids to total fatty acids percentageGCST905023884.82e-03
7816Estimated glomerular filtration rate (creatinine)GCST904284474.82e-03
7817HDL cholesterol levels (UKB data field 30760)GCST904680754.81e-03
7818FGR/LBR ratioGCST903148144.80e-03
7819Cleft hard palate NOSFING000003064.79e-03
7820Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T38ECGA0000384.79e-03
7821IDP dMRI TBSS L3 Cerebral peduncle RGCST900041854.78e-03
7822TXNRD1 levelsGCST904709944.77e-03
7823Linoleic acid levelsGCST905023074.77e-03
7824HypothyroidismGCST904681384.77e-03
7825Mean corpuscular volumeGCST0046024.76e-03
7826IDP dMRI ProbtrackX L3 cgc lGCST900043044.76e-03
7827Psoriatic arthropathiesFING000012254.74e-03
7828Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T28ECGA0000284.74e-03
7829Triglyceride levels (UKB data field 30870)GCST904681064.73e-03
7830ARHGAP25 levelsGCST904683534.73e-03
7831PCBD1 levelsGCST904701664.72e-03
7832Total testosterone levelsGCST902398194.72e-03
7833TriglyceridesGCST900187554.71e-03
7834MGLL/MITD1 ratioGCST903154364.71e-03
7835PEBP1 levelsGCST904702054.71e-03
7836CD5/CD6 ratioGCST903138604.71e-03
7837SH2B3/TBL1X ratioGCST903158414.70e-03
7838Genital prolapse | genitourinaryUKBB000002824.69e-03
7839Pregnanediol-3-glucuronide levelsGCST901999174.69e-03
7840GC levelsGCST901625644.67e-03
7841Polycystic ovarian syndromeFING000011824.67e-03
7842MED18/ZBTB16 ratioGCST903154164.66e-03
7843Seropositive rheumatoid arthritis, wideFING000012984.65e-03
7844CIRBP levelsGCST904687564.65e-03
7845Triglycerides to Total Lipids in Large VLDL percentageGCST904982874.65e-03
7846SUSD4 levelsGCST904707884.65e-03
7847CD5L levelsGCST904686404.64e-03
7848Mean corpuscular hemoglobin concentrationGCST900023284.64e-03
7849APRT/MIF ratioGCST903133364.63e-03
7850CCN1 levelsGCST904685874.63e-03
7851HematocritGCST900023834.62e-03
7852T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 2)GCST903208214.61e-03
7853JCHAIN levelsGCST904696614.61e-03
7854BA-exvivo rh volume BA4pGCST900028544.60e-03
7855GPHA2 levelsGCST904693894.60e-03
7856Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T257ECGA0002574.60e-03
7857Nontoxic diffuse goitreFING000008864.59e-03
7858LRRFIP1 levelsGCST904698054.59e-03
7859Basal cell carcinoma (PheCode 172.21)GCST904755824.59e-03
7860Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T126ECGA0001264.58e-03
7861Abnormal findings examination of lungs (PheCode 514)GCST904760434.57e-03
7862MAP4K5 levelsGCST904698554.57e-03
7863ITGB1BP2/WASF1 ratioGCST903152244.57e-03
7864REG1A levelsGCST904704474.57e-03
7865Glaucoma | GlaucomaUKBB000002864.56e-03
7866DTI TBSS MD Posterior thalamic radiation RGCST903846004.55e-03
7867Coronary artery disease (confirmatory factor analysis Factor 16)GCST903093504.55e-03
7868BTN2A1/SPINT2 ratioGCST903135504.54e-03
7869T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 97)GCST903206604.53e-03
7870Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T22ECGU0000224.53e-03
7871Urate levels (UKB data field 30880)GCST904681074.53e-03
7872FCN1 levelsGCST904692034.52e-03
78733,4-dihydroxybutyrate levelsGCST901998164.51e-03
7874Disorders of other endocrine glandsFING000004504.51e-03
7875PEAR1/TREML2 ratioGCST903156454.50e-03
7876Fracture at wrist and hand levelFING000005514.50e-03
7877Medication use (immunosuppressants)GCST900187714.48e-03
7878Autoimmune polyglandular failureFING000001354.47e-03
7879aparc-Desikan rh area cuneusGCST900031114.45e-03
7880Omega-6 fatty acid levelsGCST905021014.45e-03
7881T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 16)GCST903205794.45e-03
7882FGF2 levelsGCST904692244.44e-03
7883CNTN5/ROBO2 ratioGCST903141664.44e-03
7884Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T215ECGA0002154.44e-03
7885Serum 25-Hydroxyvitamin D level varianceGCST900006214.43e-03
7886IDP dMRI ProbtrackX MD ar rGCST900042204.43e-03
7887PRCP levelsGCST904703144.43e-03
7888Triglyceride levels in large HDLGCST900928544.43e-03
7889Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T182ECGA0001824.43e-03
7890Acquired deformities of fingers and toes | Other joint disordersUKBB000000064.42e-03
7891Father's age at death | Family historyUKBB000002414.40e-03
7892IKBKG levelsGCST904695424.40e-03
7893Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T133ECGA0001334.40e-03
7894RECK levelsGCST904704454.40e-03
7895Polyunsaturated fatty acid levelsGCST905026194.39e-03
7896Ischemic strokeGCST0069084.39e-03
7897Pulse pressure, combined automated + manual reading, adjusted by medication | Cardiovascular measurementUKBB000007204.39e-03
7898Stroke (MTAG)GCST904490634.39e-03
7899Alanine levelsGCST904970854.39e-03
7900Pulse pressure, automated reading | Cardiovascular measurementUKBB000007144.39e-03
7901MANF/SNX9 ratioGCST903153684.38e-03
7902Colon cancerGCST900118114.38e-03
7903Operative procedures - Anastomosis of mammary artery to left anterior descending coronary artery | Summary OperationsUKBB000005714.38e-03
7904Omega-6 fatty acid levelsGCST905025154.36e-03
7905Varicose veins (PheCode 454)GCST904760124.36e-03
7906HemoglobinGCST900023844.36e-03
7907LDLR/MEGF9 ratioGCST903153104.33e-03
7908Total testosterone levelsGCST902398204.33e-03
7909GlaucomaGCST904681294.33e-03
7910Triglycerides x low social support interaction (2df test)GCST905706814.33e-03
7911ANXA4/CA13 ratioGCST903132904.32e-03
7912STAT2 levelsGCST904707584.32e-03
7913GP6/SELP ratioGCST903149704.31e-03
7914IGFBP4/OGN ratioGCST903151344.31e-03
7915Retinal arteriolar tortuosityGCST902703974.30e-03
7916IDP SWI T2star right thalamusGCST900038644.29e-03
7917Other systemic involvement of connective tissue (FG)FING000011164.29e-03
7918DTI TBSS L3 Posterior thalamic radiation LGCST903845534.29e-03
7919Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T262ECGA0002624.29e-03
7920PLAUR/PRSS8 ratioGCST903156754.28e-03
7921CDH5/PCDH17 ratioGCST903139584.28e-03
7922Optic disc areaGCST0040764.28e-03
7923CRACR2A/DNMBP ratioGCST903142264.28e-03
7924IDP dMRI TBSS ISOVF FornixGCST900044824.27e-03
7925AZU1/CEACAM8 ratioGCST903134244.27e-03
7926TSC1 levelsGCST904709724.27e-03
7927Breast cancerGCST0049884.27e-03
7928Serum creatinine levelsGCST900187594.27e-03
7929Insulin fold change during an oral glucose tolerance testGCST902675684.26e-03
7930IDP dMRI TBSS OD Posterior corona radiata LGCST900044294.26e-03
7931NAGPA levelsGCST902420044.25e-03
7932Estimated glomerular filtration rate (creatinine)GCST901036344.24e-03
7933CFC1 levelsGCST904687244.23e-03
7934Phospholipids to Total Lipids in Medium HDL percentageGCST904986534.23e-03
7935SCARF1/TNFRSF14 ratioGCST903158124.23e-03
7936Corneal resistance factor (left) | Intraocular pressureUKBB000001504.23e-03
7937MPO levelsGCST900120314.22e-03
7938CXCL10 levelsGCST902747804.22e-03
7939IDS/SMPDL3A ratioGCST903151264.22e-03
7940SESTD1 levelsGCST904706044.21e-03
7941T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 121)GCST903209404.21e-03
7942Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T108ECGA0001084.20e-03
7943Total lipids in lipoprotein particles (UKB data field 23423)GCST902695204.20e-03
7944SIGLEC5 levelsGCST904706334.19e-03
7945IDP dMRI TBSS L2 Corticospinal tract RGCST900041294.19e-03
7946OLR1 levelsGCST900120204.19e-03
7947Left-hemisphere control network to hippocampus white-matter structural connectivityGCST903027564.19e-03
7948MIF/PARK7 ratioGCST903154474.18e-03
7949CCN2/VEGFC ratioGCST903137194.17e-03
7950Triglycerides in small LDLGCST904997224.16e-03
7951PPME1 levelsGCST904702984.14e-03
7952End-diastolic bi-ventricular shape (principal component 4)GCST904484834.14e-03
7953PRTFDC1 levelsGCST904703464.14e-03
7954Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T120ECGA0001204.14e-03
7955TJAP1 levelsGCST904708744.13e-03
7956CholelithiasisGCST904681184.13e-03
7957CPB1/REG1A ratioGCST903142124.13e-03
7958Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T484ECGU0004844.12e-03
7959Biliverdin levels in chronic kidney diseaseGCST902574954.12e-03
7960Aspartate aminotransferase (AST, maximum, inv-norm transformed)GCST904751184.12e-03
7961T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 42)GCST903206054.12e-03
7962aparc-Desikan lh area cuneusGCST900030774.12e-03
7963COLEC12/OGN ratioGCST903141844.12e-03
7964Gout (PheCode 274.1)GCST904763794.12e-03
7965F2R/SPINT2 ratioGCST903147374.11e-03
7966Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T171ECGA0001714.10e-03
7967SSH3 levelsGCST904707494.10e-03
7968Disorders of plasma-protein metabolism, not elsewhere classifiedFING000004554.10e-03
7969MAVS/MZT1 ratioGCST903153914.09e-03
7970BECN1 levelsGCST904684384.09e-03
7971EDAR/F2R ratioGCST903145774.09e-03
7972STX6 levelsGCST904707744.08e-03
7973Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T153ECGU0001534.08e-03
7974NSFL1C levelsGCST904700894.06e-03
7975ITGB1BP2/MED18 ratioGCST903152134.06e-03
7976Carpal tunnel syndromeFING000002574.06e-03
7977Frailty (Factor 4 - Metabolic Problems)GCST906240504.06e-03
7978Ulcerative colitis (PheCode 555.2)GCST900441554.06e-03
7979Phospholipids in VLDLGCST905002684.04e-03
7980Linoleic acid levels (UKB data field 23449)GCST902695464.04e-03
7981Free Cholesterol in HDLGCST904973794.04e-03
7982Concentration of medium HDL particlesGCST904986174.04e-03
7983CDSN/LY6D ratioGCST903139974.03e-03
7984CPA1/CTRB1 ratioGCST903142034.03e-03
7985ALDH1A1/CA3 ratioGCST903132444.03e-03
7986Chronic lymphocytic leukemiaGCST906247384.03e-03
7987Hepatic cancerGCST900186384.02e-03
7988YBX1 levelsGCST900907994.01e-03
7989aseg rh intensity PallidumGCST900037854.00e-03
7990GALNT7 levelsGCST904692994.00e-03
7991TNFRSF13B/TNFRSF9 ratioGCST903159324.00e-03
7992TFF1/TFF2 ratioGCST903159144.00e-03
7993Hypo-osmolality and hyponatraemiaFING000006484.00e-03
7994PCDH17/SEMA7A ratioGCST903156053.99e-03
7995LAP3 levelsGCST904697373.99e-03
7996Reimbursement for rheumatic diseasesFING000012473.99e-03
7997FCER2/TCL1A ratioGCST903147903.99e-03
7998Right-hemisphere default mode network to amygdala white-matter structural connectivityGCST903028493.98e-03
7999Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T187ECGA0001873.98e-03
8000IDP dMRI TBSS MO Middle cerebellar peduncleGCST900039523.98e-03